In the antithrombotic drugs market, novel oral anti-coagulants (NOACs) are gaining wide acceptance and are replacing traditionally used anti-coagulants such as Warfarin and Heparin to
Read MoreIn the antithrombotic drugs market, novel oral anti-coagulants (NOACs) are gaining wide acceptance and are replacing traditionally used anti-coagulants such as Warfarin and Heparin to
Read More